Physician profile
Blake Taylor Thompson
NPI 1649739392
$1,138.56
in general payments reported to CMS, 2019-2025
16 companies · $56.54 in 2025
The $56.54 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.69 · 2022: $147 · 2023: $191 · 2024: $689 · 2025: $56.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.80 | 2023-2025 | |
| Medtronic, INC. | $254.33 | 2023-2025 | Minimed 780g |
| Lilly USA, LLC | $90.65 | 2021-2024 | Mounjaro, Zepbound |
| Novo Nordisk INC | $90.28 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $85.43 | 2024 | Farxiga, Airsupra |
| Organon LLC | $71.36 | 2022 | |
| Exact Sciences Corporation | $61.07 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $22.79 | 2023 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $17.21 | 2023 | Vaxelis |
| Genentech USA, INC. | $16.85 | 2022 | |
| Boston Scientific Corporation | $15.81 | 2024 | |
| Amgen INC. | $15.79 | 2024 | Prolia, Evenity |
| Upsher-Smith Laboratories LLC | $15.39 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.40 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.40 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.